Whitener Capital Management, Inc. Aerie Pharmaceuticals Inc Transaction History

Whitener Capital Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 02, 2019	SELL	$28.97 - $48.21 $2,317 - $3,856	-80 Closed	0 $0
Q1 2019 May 02, 2019	BUY	$36.32 - $49.25 $2,905 - $3,940	80 New	80 $3,000
Q4 2018 Feb 06, 2019	SELL	$33.0 - $60.04 $2,640 - $4,803	-80 Closed	0 $0
Q3 2018 Nov 07, 2018	BUY	$56.15 - $73.9 $4,492 - $5,912	80 New	80 $4,000

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Whitener Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Whitener Capital Management, Inc. with notifications on news.